PatentLicensing

Resampled Efficiency™ and RE rebalancing are covered by the claims of patents, issued and pending, in the US and other countries, including US Patent Nos. 6,003,018 and 6,928,418. U.S. law provides that any use, within the United States of a patented invention during the term of the patent and without the authority of the patent owner is an infringement of the patent, while corresponding provisions apply in other jurisdictions. Any party contemplating the use of a patented article or process, as defined by the claims of a patent, must obtain authorization of the patent owner before beginning any use. A request for permission to use the invention should specify, as completely as possible, the nature of the intended use.

Permission to use our patented processes can be granted to institutional clients based on the following fee schedule. Licensing the patent does not include our software or our consulting services.

Minimum Fee: $50,000/year

Maximum Fee: $1,000,000/year

Assets Under Management	Fee
Under $1 billion	$50,000
Over $1 billion, but not over $5 billion	$50,000 plus 0.000050% of the excess over $1 billion
Over $5 billion, but not over $25 billion	$250,000 plus 0.000025% of the excess over $5 billion
Over $25 billion, but not over $250 billion	$375,000 plus 0.000010% of the excess over $25 billion
Over $250 billion, but not over $500 billion	$775,000 plus 0.000005% of the excess over $250 billion
Over $500 billion	$1,000,000

Patent Licensing